AVBP

Conviction 67HealthcareScan · Mon, Aug 10, 2026

AVBP$30.98+0.45%

ResistanceSupportVol 14

Vol MA14 475.69K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ArriVent BioPharma, Inc.PHARMACEUTICAL PREPARATIONSwww.arrivent.com ↗

Price30.98

Change+0.45%

Gap+1.01%

Rel volume1.67×

Avg volume505.29K

Avg $ vol15.5M

SMA 2030.84

SMA 5031.69

SMA 20025.65

Price vs 50-2.25%

Price vs 200+20.79%

MA stackmixed

50/200 cross—

Supertrenddown · 33.80

RSI (14)49

MACD hist0.05

MACD crossbull · 1d

Stoch %K / %D60 / 59

ADX (14)16

+DI / −DI21 / 15

RSI divergence—

MACD divergence—

ATR %+6.00%

ADR %6.74%

52w high34.74

52w low16.95

From 52w high-10.82%

Above 52w low+82.77%

New 52w highNo

SqueezeOff

Bollinger width17.49%

%B0.53

Donchian pos54.28%

Donchian high34.00

Donchian low27.40

AVWAP (52w high)32.23

vs AVWAP high-3.87%

AVWAP (52w low)25.30

vs AVWAP low+22.46%

OBV trendFlat

Chaikin MF (20)-0.06

Today vs 20d1.67×

Avg vol (14d)475.69K

Avg vol (20d)505.29K

Avg $ vol (20d)15.5M

Market cap1.44B

RS 3m (vs SPY)+1.20%

RS 6m (vs SPY)+30.34%

RS line new highNo

Trend template7/8

Technical rank64.1

1 week+4.52%

1 month-8.04%

3 months+5.02%

6 months+41.72%

1 year+67.10%

YTD+48.94%

P/E-8.68

P/B4.45

P/S—

P/FCF—

EPS-4.32

Div yield—

ROE-51.33%

ROA-47.61%

Debt/Eq—

Current13.95

EV/EBITDA-7.65

Gross margin—

Net margin—

Rev growth—

EPS growth-106.62%

Price target43.08

Target upside39.06%

Analyst ratingBuy

Institutional97.05%

Ent. value1.38B

Revenue—

Net income-43.32M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out46.57M

Employees77

ListedFri, Jan 26, 2024

Free float21.68M

Float %52.5%

Short interest7.67M

Days to cover17.9d

Short volume59.3%

Squeeze score88 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.96 vs −$0.88

Last surprise-9.1% miss

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank64.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance35.72

Support28.23

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AVBP

All disclosures →

No recent disclosed trades by Congress in AVBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AVBP · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Nolet Chris Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Hohneker John Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Peterson Kristine Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22
Parsey Merdad Director · Non-Qualified Stock Option (right to buy) · 2026-06-18	Grant	13.56K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in AVBP · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.